Tatva Chintan Pharma P/B Ratio

Current P/B Ratio
4.98
High Valuation
Very High - Significant premium, high growth expectations or speculative

Tatva Chintan Pharma (TATVA) P/B ratio is 4.98 (High), book value per share ₹340.00 vs Chemicals average P/B of -4.84 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see Tatva Chintan Pharma share price screener.

Current Valuation Metrics

P/B Ratio 4.98
Current Price ₹1770.20
Book Value/Share ₹340.00
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹782 Cr
Share Capital ₹23 Cr
Reserves & Surplus ₹758 Cr
Outstanding Shares 23,000,000
Book Value per Share ₹340.00

Valuation Signal

Signal Overvalued
Historical Avg 5.8
Historical Range 2.78 - 10.0
Percentile 40.0%

Sector Context

Sector Average -4.84
Sector Median 0.37
Sector Rank #11 of 50
Sector Percentile 22.0%

TATVA P/B Ratio — Valuation Insights & Book Value Analysis

Tatva Chintan Pharma price-to-book ratio interpretation, valuation status and historical context — current P/B 4.98 (High). Explore Tatva Chintan Pharma intrinsic price to estimate fundamental worth using multiple valuation models.

  • Stock appears overvalued with PB of 4.98, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Trading at premium to sector average PB of -4.84

Tatva Chintan Pharma P/B Ratio Historical Trend

TATVA annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Read TATVA dividend payout details for the complete payout history and dividend yield track record.

TATVA Historical P/B Ratio — Book Value Per Share & Year-End Price

Tatva Chintan Pharma annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 5.21 ₹340.0 ₹1770.20 ₹782 High
2025 4.15 ₹321.3 ₹1334.20 ₹739 High
2024 2.78 ₹320.43 ₹889.50 ₹737 Moderate
2023 6.84 ₹234.09 ₹1601.80 ₹515 High
2022 10.0 ₹215.0 ₹2150.65 ₹473 High

TATVA vs Chemicals Peers — P/B Ratio Comparison

Tatva Chintan Pharma P/B 4.98 vs Chemicals average -4.84, median 0.37 — range -156.31–0.63.

Sector Average
-4.84
Sector Median
0.37
Lowest P/B
-156.31
Highest P/B
0.63
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Citurgia Biochemicals CITURGIA -156.31 ₹1,568 Low
Chemplast Sanmar CHEMPLASTS -27.84 ₹2,611 Low
Saptak Chem & Business SCBL -24.52 ₹11 Low
Shentracon Chemicals SHENTRA -20.63 ₹48 Low
Organic Coatings ORGCOAT -9.73 ₹18 Low
Indian Acrylics INDIANACRY -6.36 ₹78 Low
National Oxygen NOL -4.87 ₹29 Low
Gayatri Bioorganics GAYATRIBI -1.67 ₹64 Low
Tecil Chemicals & Hydro … TECILCHEM -1.2 ₹24 Low
Aadi Industries AADIIND -1.14 ₹8 Low